Biblio

Author Title [ Type(Asc)] Year
Filters: Author is Spina, Michele  [Clear All Filters]
Journal Article
Arcaini L, Bommier C, Alderuccio JPablo, Merli M, Fabbri N, Nizzoli MElena, Maurer MJ, Tarantino V, Ferrero S, Rattotti S, et al. Marginal zone lymphoma international prognostic index: a unifying prognostic index for marginal zone lymphomas requiring systemic treatment. EClinicalMedicine. 2024;72:102592.
Ferreri AJM, Sassone M, Angelillo P, Zaja F, Re A, Di Rocco A, Spina M, Fabbri A, Stelitano C, Frezzato M, et al. Long-Lasting Efficacy And Safety Of Lenalidomide Maintenance In Patients With Relapsed Diffuse Large B-Cell Lymphoma Who Are Not Eligible For Or Failed Autologous Transplantation. Hematol Oncol. 2020.
Stathis A, Pirosa MCristina, Orsucci L, Feugier P, Tani M, Ghesquières H, Musuraca G, Rossi FGaia, Merli F, Guieze R, et al. IELSG38: phase II trial of front-line chlorambucil plus subcutaneous rituximab induction and maintenance in mucosa-associated lymphoid tissue lymphoma. Haematologica. 2024.
Ferreri AJM, Cattaneo C, Lleshi A, Verga L, Allione B, Facchetti F, Ponzoni M, Foppoli M, Ferrari D, Rigacci L, et al. A dose-dense short-term therapy for human immunodeficiency virus/acquired immunodeficiency syndrome patients with high-risk Burkitt lymphoma or high-grade B-cell lymphoma: safety and efficacy results of the "CARMEN" phase II trial. Br J Haematol. 2020.
Pagani C, Rusconi C, Pria ADalla, Ravano E, Schommers P, Bastos-Oreiro M, Verga L, Gini G, Spina M, Arcaini L, et al. Do MYC rearrangements Matter in HIV-Associated Large B Cell Lymphomas? "EUROMYC" Study (a European retrospective study). Blood Adv. 2024.
Zanussi S, Bortolin MTeresa, Pratesi C, Tedeschi R, Basaglia G, Abbruzzese L, Mazzucato M, Spina M, Vaccher E, Tirelli U, et al. Autograft HIV-DNA Load Predicts HIV-1 Peripheral Reservoir After Stem Cell Transplantation for AIDS-Related Lymphoma Patients. AIDS Res Hum Retroviruses. 2015;31(1):150-159.